Troy Ignelzi
Board Member
Contineum Therapeutics, Inc. (CTNM)Equibles does not estimate personal net worth.
Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTNM alertsAbout Troy Ignelzi
Troy Ignelzi is recorded as Board Member at Contineum Therapeutics, Inc. (CTNM). The newest filing on record that lists Troy Ignelzi as Board Member at Contineum Therapeutics, Inc. (CTNM) is dated April 30, 2026. Contineum Therapeutics, Inc. reported in an 8-K filed May 20, 2024 that Troy Ignelzi was appointed Class I director, effective May 20, 2024. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), Peter T. Slover (CFO), John S. Healy (General Counsel) and 6 others.
“On May 20, 2024, the board of directors (the "Board") of Contineum Therapeutics, Inc. (the "Company") appointed Troy Ignelzi as a member of its Board, effective immediately.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Contineum Therapeutics, Inc.
- Carmine N. Stengone CEO, Board Member
- Peter T. Slover CFO
- John S. Healy General Counsel
- Diego Miralles Board Member
- Diego Miralles, M.D. Board Member
- Lori M. Lyons-Williams Board Member
- Olivia Ware Board Member
- Sarah Boyce Board Member
- Todd Brady Board Member